Tag | Content |
---|
EnhancerAtlas ID | HS034-31382 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr9:140639890-140640520 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFE2L1 | MA0089.2 | chr9:140640360-140640375 | ATTGCTGAGTCATGC | - | 8.55 | Nfe2l2 | MA0150.2 | chr9:140640362-140640377 | TGCTGAGTCATGCCT | - | 7.3 | SREBF2 | MA0596.1 | chr9:140639950-140639960 | ATCACCCCAT | - | 6.02 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_10754 | chr9:140638878-140640811 | CD19_Primary | SE_11232 | chr9:140638468-140641129 | CD20 | SE_32711 | chr9:140638399-140641999 | GM12878 | SE_59172 | chr9:140631350-140657613 | Ly3 | SE_62965 | chr9:140561512-140658488 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH09I137744 | chr9 | 140638883 | 140641502 |
|
Enhancer Sequence | GATAATTATT AGTTTTTTCT CCTCTTATAT GAAGAAGCAT GAGGAAGAAA ACACAGCATC 60 ATCACCCCAT TGTCCTGGTG GCTCTGGCAC TCTGAAACAG TCACTACAGG AACTTCCTTA 120 GACGTGCCCA GCACAGCCCA GCCCTCCCCG AAGGACAGGC AGCCCTGACT GCACCGTGGG 180 GAAGCAGCTA CCCCAGCAGC TGCCGCGGTC TCTGCACACA CGTGTCTGTC GCTCCAGTGC 240 ACTGTCTGTT CAGCTGTGTT ACGCTCTTTC TGTCAAGTTA CAAGGGGTAT TCAGTGTCAC 300 AGTTTTGCTG AGTATGCCGG AGGCTCATAA GTGCTGTCTG CATTTACAGT GTAGCACTTT 360 GATGTCACCA GGCCACCTCT GACTGTATCC TTCCACCTGC AGAGACCTGA GGGGTGTGGT 420 TTCCTCACCT TCCCCAGCAG GGCTGCCTTC TTGGAGTCCA GCAGCTCTTC ATTGCTGAGT 480 CATGCCTGGG GCTGAGCAGC CAGCCACCAG TGTTTGTTCC TCTGTAAGCC GCTTGCTAAA 540 TAGCCCCTGC TCATTTTTCT TCTGGATTTT GCATCTTTTG AATGTAGTCT GACGATCTTT 600 TTTGTCAACG AAGAGTTGAT CTGTTGGCTC 630
|